Organon & Co. - Common Stock (OGN)

Q3 2023 13F Holders as of 9/30/2023

Type / Class
Equity / Common Stock
Shares outstanding
260M
Number of holders
701
Total 13F shares, excl. options
197M
Shares change
-1.67M
Total reported value, excl. options
$3.42B
Value change
-$41.7M
Put/Call ratio
1.91
Number of buys
286
Number of sells
-314
Price
$17.36

Significant Holders of Organon & Co. - Common Stock (OGN) as of Q3 2023

784 filings reported holding OGN - Organon & Co. - Common Stock as of Q3 2023.
Organon & Co. - Common Stock (OGN) has 701 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 197M shares of 260M outstanding shares and own 75.76% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (31.4M shares), BlackRock Inc. (15.7M shares), STATE STREET CORP (13.7M shares), Mawer Investment Management Ltd. (12.8M shares), Invesco Ltd. (10.2M shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (9.28M shares), GEODE CAPITAL MANAGEMENT, LLC (5.72M shares), LORD, ABBETT & CO. LLC (5.03M shares), JANUS HENDERSON GROUP PLC (3.58M shares), and Sound Shore Management Inc /CT/ (3.46M shares).
This table shows the top 701 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.